Altogether, these studies were carried out on patients with advanced diseases and therefore, an even stronger effect at an earlier stage of the disease would be conceivable, especially considering resveratrol’s capability to modulate tumor initiation, promotion as well as progression, summarizing all p53-involved stages of CRC development. The gene discussed is TP53; the disease is neoplasm.